158 related articles for article (PubMed ID: 38505168)
21. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
[TBL] [Abstract][Full Text] [Related]
22. Biocompatibility, cytotoxicity and antibacterial effects of meropenem-loaded mesoporous silica nanoparticles against carbapenem-resistant
Memar MY; Yekani M; Ghanbari H; Shahi S; Sharifi S; Maleki Dizaj S
Artif Cells Nanomed Biotechnol; 2020 Nov; 48(1):1354-1361. PubMed ID: 33236938
[TBL] [Abstract][Full Text] [Related]
23. An optimized mesoporous silica nanosphere-based carrier system with chemically removable Au nanoparticle caps for redox-stimulated and targeted drug delivery.
Zhang L; Wei F; Al-Ammari A; Sun D
Nanotechnology; 2020 Nov; 31(47):475102. PubMed ID: 32413886
[TBL] [Abstract][Full Text] [Related]
24. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
25. Extra-Large Pore Mesoporous Silica Nanoparticles for Directing in Vivo M2 Macrophage Polarization by Delivering IL-4.
Kwon D; Cha BG; Cho Y; Min J; Park EB; Kang SJ; Kim J
Nano Lett; 2017 May; 17(5):2747-2756. PubMed ID: 28422506
[TBL] [Abstract][Full Text] [Related]
26. Thiol-Functionalized, Antioxidant, and Osteogenic Mesoporous Silica Nanoparticles for Osteoporosis.
Rasool N; Negi D; Singh Y
ACS Biomater Sci Eng; 2023 Jun; 9(6):3535-3545. PubMed ID: 37172017
[TBL] [Abstract][Full Text] [Related]
27. Functionalized Mesoporous Silica Nanoparticles for Drug-Delivery to Multidrug-Resistant Cancer Cells.
Igaz N; Bélteky P; Kovács D; Papp C; Rónavári A; Szabó D; Gácser A; Kónya Z; Kiricsi M
Int J Nanomedicine; 2022; 17():3079-3096. PubMed ID: 35859731
[TBL] [Abstract][Full Text] [Related]
28. PrP
Go G; Lee CS; Yoon YM; Lim JH; Kim TH; Lee SH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671292
[TBL] [Abstract][Full Text] [Related]
29. EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer.
Li Y; Duo Y; Bao S; He L; Ling K; Luo J; Zhang Y; Huang H; Zhang H; Yu X
Int J Nanomedicine; 2017; 12():6239-6257. PubMed ID: 28894364
[TBL] [Abstract][Full Text] [Related]
30. The advancing of polymeric core-shell ZnO nanocomposites containing 5-fluorouracil for improving anticancer activity in colorectal cancer.
Mohammadian S; Avan A; Khazaei M; Maghami P
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):899-911. PubMed ID: 37530786
[TBL] [Abstract][Full Text] [Related]
31. Co-Delivery of Silymarin and Metformin Dual-Loaded in Mesoporous Silica Nanoparticles Synergistically Sensitizes Breast Cancer Cell Line to Mitoxantrone Chemotherapy.
Rezaei Harandi Z; Heidari R; Reiisi S
IEEE Trans Nanobioscience; 2023 Oct; 22(4):872-880. PubMed ID: 37022888
[TBL] [Abstract][Full Text] [Related]
32. Luciferase and luciferin co-immobilized mesoporous silica nanoparticle materials for intracellular biocatalysis.
Sun X; Zhao Y; Lin VS; Slowing II; Trewyn BG
J Am Chem Soc; 2011 Nov; 133(46):18554-7. PubMed ID: 22007786
[TBL] [Abstract][Full Text] [Related]
33. Lipid surface modifications increase mesoporous silica nanoparticle labeling properties in mesenchymal stem cells.
Rosenbrand R; Barata D; Sutthavas P; Mohren R; Cillero-Pastor B; Habibovic P; van Rijt S
Int J Nanomedicine; 2018; 13():7711-7725. PubMed ID: 30538454
[TBL] [Abstract][Full Text] [Related]
34. Selenium-incorporated mesoporous silica nanoparticles for osteosarcoma therapy.
He L; Habibovic P; van Rijt S
Biomater Sci; 2023 May; 11(11):3828-3839. PubMed ID: 37074160
[TBL] [Abstract][Full Text] [Related]
35. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles.
He Q; Zhang J; Chen F; Guo L; Zhu Z; Shi J
Biomaterials; 2010 Oct; 31(30):7785-96. PubMed ID: 20674009
[TBL] [Abstract][Full Text] [Related]
36. Gold-capped mesoporous silica nanoparticles as an excellent enzyme-responsive nanocarrier for controlled doxorubicin delivery.
Eskandari P; Bigdeli B; Porgham Daryasari M; Baharifar H; Bazri B; Shourian M; Amani A; Sadighi A; Goliaei B; Khoobi M; Saboury AA
J Drug Target; 2019 Dec; 27(10):1084-1093. PubMed ID: 30900473
[TBL] [Abstract][Full Text] [Related]
37. Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy.
Yang Y; Lin Y; Di D; Zhang X; Wang D; Zhao Q; Wang S
J Colloid Interface Sci; 2017 Dec; 508():323-331. PubMed ID: 28843922
[TBL] [Abstract][Full Text] [Related]
38. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
Zhu Y; Wang B; Chen J; He J; Qiu X
Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
[TBL] [Abstract][Full Text] [Related]
39. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N
Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341
[TBL] [Abstract][Full Text] [Related]
40. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
